ICCVAM is leading development of a strategic roadmap to establish new approaches for evaluating the safety of chemicals and medical products in the United States: comments welcomed through August 31
ICCVAM's mission is to facilitate development, validation, and regulatory acceptance of new and revised regulatory test methods that reduce, refine, and replace the use of animals in testing while maintaining and promoting scientific quality and the protection of human health, animal health, and the environment.
Significant changes to the focus and priorities of NICEATM and ICCVAM (see editorial by NIEHS and NTP Director Linda Birnbaum, Environmental Health Perspectives, February 2013) occurred in 2013. These changes better aligned ICCVAM and NICEATM with the vision laid out by the National Academy of Sciences in the 2007 National Research Council report Toxicity Testing in the 21st Century: A Vision and a Strategy.
ICCVAM and NICEATM developed a “A New Vision and Direction for ICCVAM” describing the initial steps towards this goal. The document discussed:
In addition, ICCVAM stated the intent of its member agencies to take a more active role in priority setting and operations of the Committee and to devote more effort to fewer focus areas.
ICCVAM made this document available in draft form for comment in September 2013. Attendees at that month’s meeting of the Scientific Advisory Committee on Alternative Toxicological Methods discussed the document and proposed initial steps.